Back to Journals » Cancer Management and Research » Volume 10

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Total article views   Abstract views HTML views PDF downloads Totals
5,086 Dovepress* 4,571 317+ 491 4,888
PubMed Central* 0 198 74 198
Totals 4,571 515 565 5,086
*Since 9 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar